| Financial Year |
March 31 2023 |
| Monetary Funds |
998,135,737.03 |
| Held-for-trading Financial Assets |
15,000,000.00 |
| Notes Receivable |
97,854,534.30 |
| Accounts Receivable |
617,442,186.09 |
| Advances to Suppliers |
36,665,803.17 |
| Other Receivables |
19,427,532.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
889,607,249.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
64,673,205.44 |
| Total Current Assets |
2,739,714,248.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,401,629.54 |
| Investment Properties |
3,092,688.52 |
| Fixed Assetes |
302,565,818.29 |
| Under-construction Projects |
3,829,376.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,290,765.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,207,268.04 |
| Deferred Income Tax Assets |
24,547,721.52 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
554,288,384.25 |
| Total Assets |
3,294,002,632.98 |
| Short-Term Loans |
606,997,916.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
243,410,169.93 |
| Accounts Payable |
567,740,617.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,183,134.55 |
| Taxes Payable |
51,903,254.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,752,188.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,297,565.04 |
| Other Current Liabilities |
108,040,519.26 |
| Sub-Total of Current Liabilities |
1,723,815,192.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,365,858.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
211,248,404.27 |
| Total Liabilities |
1,935,063,596.27 |
| Paid-In Capital(Or Share Stock) |
1,160,542,453.00 |
| Capital Surplus |
1,290,744,156.83 |
| Surplus Reserve |
70,970,194.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,180,561,170.90 |
| Minority Stockholder's Interest |
30,446,383.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,328,492,652.91 |
| Owner's Equity（Stockholder's Equity） |
1,358,939,036.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,294,002,632.98 |
